Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
HCA Stock Forecast 2025-2026
$472.65
Current Price
$112.31B
Market Cap
Buy 14
Hold 9
Sell 1
Wall St Analyst Ratings
Distance to HCA Price Targets
+11.1%
To High Target of $525.00
+3.7%
To Median Target of $490.00
-22.1%
To Low Target of $368.00
HCA Price Momentum
-0.8%
1 Week Change
+12.5%
1 Month Change
+37.8%
1 Year Change
+57.5%
Year-to-Date Change
-1.5%
From 52W High of $479.95
+63.0%
From 52W Low of $289.98
📊 TOP ANALYST CALLS
Did HCA Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if HCA Healthcare is one of their latest high-conviction picks.
Latest HCA Stock Price Targets & Analyst Predictions
Based on our analysis of 45 Wall Street analysts, HCA has a bullish consensus with a median price target of $490.00 (ranging from $368.00 to $525.00). The overall analyst rating is Strong Buy (8.2/10). Currently trading at $472.65, the median forecast implies a 3.7% upside. This outlook is supported by 14 Buy, 9 Hold, and 1 Sell ratings.
The most optimistic forecast comes from Brian Tanquilut at Jefferies, projecting a 11.1% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
HCA Analyst Ratings
14
Buy
9
Hold
1
Sell
HCA Price Target Range
Low
$368.00
Average
$490.00
High
$525.00
Current: $472.65
Latest HCA Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for HCA.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 13, 2025 | Wells Fargo | Stephen Baxter | Equal-Weight | Maintains | $431.00 |
| Oct 28, 2025 | Jefferies | Brian Tanquilut | Buy | Maintains | $525.00 |
| Oct 27, 2025 | Barclays | Andrew Mok | Overweight | Maintains | $494.00 |
| Oct 27, 2025 | RBC Capital | Ben Hendrix | Outperform | Maintains | $482.00 |
| Oct 27, 2025 | Goldman Sachs | Scott Fidel | Buy | Maintains | $520.00 |
| Oct 27, 2025 | Keybanc | Matthew Gillmor | Overweight | Maintains | $475.00 |
| Oct 27, 2025 | Stephens & Co. | Raj Kumar | Overweight | Maintains | $500.00 |
| Oct 27, 2025 | UBS | Andrew Mok | Buy | Maintains | $525.00 |
| Oct 27, 2025 | B of A Securities | Joanna Gajuk | Neutral | Maintains | $470.00 |
| Oct 27, 2025 | Mizuho | Ann Hynes | Outperform | Maintains | $505.00 |
| Oct 27, 2025 | Truist Securities | David Macdonald | Buy | Maintains | $495.00 |
| Oct 27, 2025 | Oppenheimer | Michael Wiederhorn | Outperform | Maintains | $500.00 |
| Oct 27, 2025 | TD Cowen | Ryan Langston | Buy | Maintains | $490.00 |
| Oct 17, 2025 | Mizuho | Ann Hynes | Outperform | Maintains | $475.00 |
| Oct 14, 2025 | Goldman Sachs | Scott Fidel | Buy | Assumes | $470.00 |
| Oct 14, 2025 | UBS | Andrew Mok | Buy | Maintains | $495.00 |
| Oct 8, 2025 | Keybanc | Matthew Gillmor | Overweight | Maintains | $465.00 |
| Oct 7, 2025 | Wells Fargo | Stephen Baxter | Equal-Weight | Maintains | $412.00 |
| Oct 7, 2025 | Cantor Fitzgerald | Sarah James | Overweight | Reiterates | $444.00 |
| Sep 18, 2025 | Barclays | Andrew Mok | Overweight | Maintains | $445.00 |
HCA Healthcare Inc. (HCA) Competitors
The following stocks are similar to HCA Healthcare based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
HCA
HCA Healthcare
mkt cap
113.25B
HCA Healthcare Inc. (HCA) Financial Data
HCA Healthcare Inc. has a market capitalization of $112.31B with a P/E ratio of 18.3x. The company generates $74.37B in trailing twelve-month revenue with a 8.5% profit margin.
Revenue growth is +9.6% quarter-over-quarter, while maintaining an operating margin of +15.5% and return on equity of +1,037.8%.
Valuation Metrics
Market Cap
$112.31B
Enterprise Value
$156.51B
P/E Ratio
18.3x
PEG Ratio
0.4x
Price/Sales
1.5x
Growth & Margins
Revenue Growth (YoY)
+9.6%
Gross Margin
+41.8%
Operating Margin
+15.5%
Net Margin
+8.5%
EPS Growth
+29.4%
Financial Health
Cash/Price Ratio
+1.0%
Current Ratio
0.9x
Debt/Equity
-21.5x
ROE
+1,037.8%
ROA
+12.2%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
HCA Healthcare Inc. (HCA) Business Model
About HCA Healthcare Inc.
What They Do
Operates healthcare facilities across the U.S.
Business Model
The company generates revenue by providing a range of healthcare services through its network of hospitals, surgery centers, and urgent care facilities. Its model focuses on delivering comprehensive medical care, including acute, outpatient, and specialty services, ensuring a steady stream of income from patient care.
Additional Information
HCA Healthcare is known for its significant investments in patient care technology and practice management, emphasizing clinical excellence, research, and education. Its extensive operational reach enhances healthcare accessibility and quality, while its strategic initiatives position it well within the evolving healthcare landscape.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
226,000
CEO
Mr. Samuel N. Hazen
Country
United States
IPO Year
2011
Website
hcahealthcare.comHCA Healthcare Inc. (HCA) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
The Zacks Analyst Blog Highlights Southern Copper, HCA Healthcare, General Motors, Morgan Stanley and Capital One Financial
Five non-tech powerhouses Southern Copper, HCA Healthcare, General Motors, Morgan Stanley, and Capital One are Zacks' top-ranked picks to drive portfolio gains in 2026.
Nov 13, 2025
By Zacks Equity Research
Press Releases
Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Nov 13, 2025
By Zacks Equity Research
Tale of the Tape
5 Top-Ranked Non-Tech Giants to Maximize Your Portfolio Returns in 2026
Five non-tech powerhouses, SCCO, HCA, GM, MS and COF, shine as strong 2026 portfolio picks.
Nov 12, 2025
By Nalak Das
Analyst Blog
Latest News
Quick Summary
HCA Healthcare will participate in the UBS Global Healthcare Conference on November 12, 2025, with CFO Mike Marks presenting.
Why It Matters
HCA Healthcare's participation in the UBS Global Healthcare Conference highlights its visibility and credibility in the market, potentially influencing investor sentiment and stock performance.
Source: Seeking Alpha
Market Sentiment:
Neutral
HCA Healthcare Commits $150,000 in Support of Veterans and Their Families in Honor of Veterans Day
4 days ago
Quick Summary
HCA Healthcare will donate $150,000 to veteran support organizations for Veterans Day, with $50,000 going to Operation Stand Down. The company has hired over 65,000 veterans since 2012.
Why It Matters
HCA Healthcare's $150,000 donation to veteran organizations highlights its commitment to corporate social responsibility and can enhance its brand reputation, potentially attracting socially conscious investors.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
HCA Healthcare, Inc. will present at the 2025 Stephens Annual Investment Conference on November 20, 2025, at 1:00 PM CT. Details will be available on their Investor Relations website.
Why It Matters
HCA Healthcare's upcoming presentation could signal strategic updates or financial outlooks, influencing stock performance and investor sentiment in the healthcare sector.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Zacks.com has released its daily Analyst Blog, highlighting stocks and market news as of November 11, 2025, which may impact investor decisions.
Why It Matters
The Zacks Analyst Blog provides insights and analysis on stocks, which can influence investment decisions and market trends, impacting stock performance and investor strategies.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Quick Summary
Five non-tech companies—SCCO, HCA, GM, MS, and COF—are highlighted as strong portfolio picks for 2026.
Why It Matters
Strong performance from SCCO, HCA, GM, MS, and COF suggests potential growth, indicating sectors outside tech may offer valuable investment opportunities for 2026.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
The Zacks Focus List provides investors with top-rated stock recommendations, serving as a resource for building a successful investment portfolio.
Why It Matters
The Zacks Focus List highlights top-rated stocks, helping investors identify high-potential picks to enhance portfolio performance and maximize returns.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About HCA Stock
What is HCA Healthcare Inc.'s (HCA) stock forecast for 2026?
Based on our analysis of 45 Wall Street analysts, HCA Healthcare Inc. (HCA) has a median price target of $490.00. The highest price target is $525.00 and the lowest is $368.00.
Is HCA stock a good investment in 2026?
According to current analyst ratings, HCA has 14 Buy ratings, 9 Hold ratings, and 1 Sell ratings. The stock is currently trading at $472.65. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for HCA stock?
Wall Street analysts predict HCA stock could reach $490.00 in the next 12 months. This represents a 3.7% increase from the current price of $472.65. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is HCA Healthcare Inc.'s business model?
The company generates revenue by providing a range of healthcare services through its network of hospitals, surgery centers, and urgent care facilities. Its model focuses on delivering comprehensive medical care, including acute, outpatient, and specialty services, ensuring a steady stream of income from patient care.
What is the highest forecasted price for HCA HCA Healthcare Inc.?
The highest price target for HCA is $525.00 from Brian Tanquilut at Jefferies, which represents a 11.1% increase from the current price of $472.65.
What is the lowest forecasted price for HCA HCA Healthcare Inc.?
The lowest price target for HCA is $368.00 from at , which represents a -22.1% decrease from the current price of $472.65.
What is the overall HCA consensus from analysts for HCA Healthcare Inc.?
The overall analyst consensus for HCA is bullish. Out of 45 Wall Street analysts, 14 rate it as Buy, 9 as Hold, and 1 as Sell, with a median price target of $490.00.
How accurate are HCA stock price projections?
Stock price projections, including those for HCA Healthcare Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: November 15, 2025 12:43 PM UTC